Evidence map›Paper›PMID 34361767›Full record

ArticleMolecules (Basel, Switzerland)2021

Non-Specific GH30_7 Endo-β-1,4-xylanase from

Katarína Šuchová, Nikolaj Spodsberg, Kristian B R Mørkeberg Krogh, Peter Biely, Vladimír Puchart

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Recent progress in the microbial production of Xylanase.World journal of microbiology & biotechnology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Yeast GH30 Xylanase fromMolecules (Basel, Switzerland) · 2022
    Article
  7. Catalytic Diversity of GH30 Xylanases.Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Katarína ŠuchováInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-845 38 Bratislava, Slovakia.ORCID 0000-0001-5529-8383
Nikolaj SpodsbergNovozymes A/S, Biologiens Vej 2, Kongens Lyngby, DK-2800 Lyngby-Taarbæk, Denmark.
Kristian B R Mørkeberg KroghNovozymes A/S, Biologiens Vej 2, Kongens Lyngby, DK-2800 Lyngby-Taarbæk, Denmark.
Peter BielyInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-845 38 Bratislava, Slovakia.
Vladimír PuchartInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-845 38 Bratislava, Slovakia.ORCID 0000-0002-6434-3462
Institute of Chemistry of the Slovak Academy of Sciences · SKNovozymes (Denmark) · DK

Funding

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 2/0016/18
6 · The paper itself

Abstract

This study describes the catalytic properties of a GH30_7 xylanase produced by the fungus

Indexed as

Amino Acid SequenceArabinoseCarbohydrate SequenceEndo-1,4-beta XylanasesFungal ProteinsGene ExpressionGlucuronatesHydrolysisOligosaccharidesSequence AlignmentSequence Homology, Amino AcidSubstrate SpecificityTalaromycesXylans(1-4)-xylanArabinosearabinoxylanEndo-1,4-beta XylanasesFungal ProteinsGlucuronatesglucuronoxylanOligosaccharidesXylansxylooligosaccharideGH30_7 subfamilyglycoside hydrolase family 30non-specific endo-β-1,4-xylanasesubstrate specificityTalaromyces leycettanus

Identifiers

PMID34361767
PMCPMC8347862
OpenAlexW3184074532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.